Alex Kwan, PhD, is an Associate Professor at Cornell University’s Meinig School of Biomedical Engineering. He previously held the position of Associate Professor in the Department of Psychiatry at the Yale University School of Medicine. Dr. Kwan’s pioneering research aims to uncover the psychoplastogenic effects of psychedelic drugs such as ketamine and psilocybin, and his 2021 publication won…


Previous articlePsyBio Therapeutics Latest U.S. PCT (Non-Provisional) Patent Application Accepted
Next articlePsyence Group Receives Phase IIa Clinical Trial Approval from the UK Medicines and Healthcare Products Regulatory Agency (MHRA)